Latest Regulatory News

BCAL Diagnostics is preparing to launch its Avantect® pancreatic and ovarian cancer blood tests in Australia by January 2026, following key regulatory approvals and promising clinical data. The company also broadens the reach of its BREASTESTplus™ breast cancer test, targeting a larger segment of women with dense breast tissue.

Decidr AI Industries has announced a strategic acquisition of Delaware-based Sugarwork Inc., marking its official entry into the US market and enhancing its Agentic AI platform with advanced knowledge transfer capabilities.

Cyclopharm Limited reaffirms its ambitious target of 250–300 US Technegas installations by late 2026, driven by FDA approval, CMS reimbursement, and a growing pipeline of healthcare sites. The company reports record half-year revenue growth, signaling strong momentum in the expanding lung imaging market.

Nuix Limited’s 2025 AGM revealed steady ACV growth, a leadership transition, and a strategic push centered on its Nuix Neo platform to fuel future expansion.

Geopacific Resources has extended the Woodlark Gold Project Definitive Feasibility Study to Q1 2026, aiming to integrate optimisation and de-risking measures amid a gold price surge and promising drilling results.

Aquirian Limited is accelerating its growth trajectory through strategic joint ventures and a major expansion of its Wubin facility, aiming to reshape the mining services landscape with advanced drill and blast technologies.

Augustus Minerals has expanded gold anomalies at its Music Well project in Western Australia through extensive soil sampling, prioritizing Clifton East for upcoming drilling. The discovery of new undercover targets signals promising exploration upside in a prolific gold region.

Nufarm Limited has announced Rico Christensen as its new CEO, effective January 2026, succeeding Greg Hunt who will stay on as advisor until mid-2026. Christensen brings three decades of global agricultural sector expertise and a strong operational focus.

Nufarm Limited reported a $165.3 million statutory loss for FY25, driven by restructuring costs in Seed Technologies despite strong Crop Protection growth. A CEO transition and refinancing moves set the stage for FY26.

Webjet Group reports steady first-half results with a 16% rise in underlying profit and announces its inaugural fully franked interim dividend, signalling confidence despite a challenging travel market.

Webjet Group reported a slight revenue dip and a mixed earnings performance for the half-year ended September 2025, while unveiling its inaugural dividend and receiving a non-binding takeover offer from Helloworld Travel.

Helloworld Travel Limited has made a non-binding indicative all-cash offer to acquire the remaining shares of Webjet Group at A$0.90 per share, signaling a potential major consolidation in the online travel sector.